HOME >> MEDICINE >> NEWS
Media undermine efforts to tackle nicotine addiction

Inaccurate media reports surrounding the safety of new smoking cessation drugs are undermining the treatment of nicotine addiction, according to an editorial in this week's BMJ.

Professor Linda Ferry presents two scenarios that illustrate the struggle between the press and medical experts to investigate and report concerns about the safety of new drugs for smoking cessation, and the effect this struggle has on reported attempts to quit smoking.

In the United Kingdom, bupropion hydrochloride (Zyban) was heralded by the media as a wonder drug when it was released in 2000. Not surprisingly, smokers queued up in waiting rooms, expecting their tobacco addiction to be vanish with this new pill.

The public enthusiasm changed abruptly in February 2001 when a London newspaper profiled a few dramatic reports of deaths in smokers using bupropion. Although experts remain convinced of the safety of bupropion, the demand for treatment has declined.

A similar shift in public opinion followed media reports in the United States about an increased risk of heart attack associated with nicotine patches. A subsequent trial showed that patches were safe to use, specifically in patients with heart disease, but many smokers still believe the original media messages that if I use a patch and smoke even one cigarette, I might have a heart attack.

Clinicians should give clear messages to their patients that it is much safer to use either of these drugs to help their attempts to quit than to continue smoking, says the author. Unfortunately, much damage has been done.

Tobacco treatment specialists and public health agencies need to refute the inaccuracies of the media and present a clear picture of the enormous problem of preventable disability and the 120,000 tobacco related deaths a year from the 13 million smokers in the United Kingdom, she concludes.


'"/>

Contact: Emma Wilkinson
ewilkinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
6-Jun-2002


Page: 1

Related medicine news :

1. Media update: GSA underscores hottest meeting topics
2. Media invitation first annual EDCTP Forum
3. Media invitation - European Society of Cardiology Congress 2004
4. Media invitation: The Movement Disorder Societys 7th International Congress
5. Media Advisory-- Results of California autism epidemiology study to be unveiled
6. Review of preliminary observations concludes the Mayo Clinic Natl Conf on Medicine and the Media
7. Media focus on endostatin helped -- not hurt --
8. Media advisory: Mayo Clinic study finds infliximab safe and beneficial for Crohns disease
9. Media coverage of new drugs is often misleading
10. Media advisory: Mayo Clinic study shows increased incidence of migraines in women
11. American Heart Association Media Advisory: Cholesterol Lowering Margarines

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... ... Getting enough sleep affects much more than energy – it also has mental and physical ... compromise motor reaction time, which can increase the risk of having a car accident. ... from the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce its ... has been in place since the RBMA was founded in 1968 with all board ... Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for Clinical ...
(Date:4/28/2017)... ... April 28, 2017 , ... From April ... of Urgent Care Medicine will host industry leaders for the annual spring Convention ... those in the industry adapt to the issues currently affecting urgent care and ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... which name the Creator responds to and which He does not. Yisrayl says with ... which one is the true name, but he says with a little Scripture, backed with ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation Limited, a ... its Nova Skin Sciences division, recently announced the launch of Allumière Antiaging Cream, ... power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark Extract and ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., a ... drug prescribing process, today announced it closed $25 million in ... venture capital firm based in Seattle ... Venture Partners . The Series B round included participation from ... in 2014, and GV (formerly Google Ventures). As ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive ... offering. ... market was valued at US$ 7,167.6 Mn in 2015, and ... at a CAGR of 5.6% from 2016 to 2024. ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
Breaking Medicine Technology:
Cached News: